“…In our previous study, the isolation of 17 xanthones including three new xanthones, mangostenol and mangostenones A and B, from the green fruit (14-week maturity stage) of this plant and their antituberculosis activity were already described. 10,11) In a continuation of this work, the EtOAc-soluble extract obtained from the young fruit (7-week maturity stage) of G. mangostana was subjected to a chemical investigation leading to the isolation and structural elucidation of three new prenylated xanthones, mangostenones C (1), D (2), and E (3), in addition to 16 previously reported xanthones, thwaitesixanthone (4), 12) demethylcalabaxanthone (5), 11) garcinone B (6), 10) compound 7, 11) b-mangostin (8), 10) 8-desoxygartanin (9), 13) gartanin (10), 14) garcinone E (11), 15) the major metabolite a-mangostin (12), 10) mangostinone (13), 10) the second major metabolite g-mangostin (14), 11) mangostanol (15), 10) mangostanin (16), 11) garcinone D (17), 11) garcinone C (18), 16) and the third major metabolite 11-hydroxy-1-isomangostin (19). 17) We here report on the structural elucidation of the three new compounds and the in vitro cytotoxic activities of xanthones 1-19 against three human cancer cell lines, epidermoid carcinoma of the mouth (KB), breast cancer (BC-1), and small cell lung cancer (NCI-H187).…”